RESUMO
No disponible
Assuntos
Qualidade dos Medicamentos Homeopáticos , Medicamento Homeopático , Rotulagem de Medicamentos , Aprovação de Drogas , /epidemiologiaRESUMO
No disponible
Assuntos
Humanos , Masculino , Feminino , Anamnese Homeopática , Formulário Homeopático/classificação , Formulário Homeopático/normas , Overdose de Drogas/epidemiologia , Overdose de Drogas/metabolismo , Farmacodinâmica do Medicamento Homeopático/métodos , Farmacodinâmica do Medicamento Homeopático/normas , Qualidade dos Medicamentos Homeopáticos , Classificação dos Medicamentos HomeopáticosAssuntos
Humanos , Masculino , Feminino , Medicina Nuclear/métodos , Medicina Nuclear/tendências , Compostos Radiofarmacêuticos , Repertório Homeopático/classificação , Repertório Homeopático/tendências , Controle de Formulários e Registros/métodos , Controle de Formulários e Registros , Registros/normas , Dosimetria/métodos , Dosimetria/políticas , Compostos Radiofarmacêuticos/administração & dosagem , Compostos Radiofarmacêuticos/antagonistas & inibidores , Compostos Radiofarmacêuticos/farmacologia , Espanha/epidemiologia , Repertório Homeopático/métodos , Repertório Homeopático , Overdose de Drogas/terapia , Dosimetria Termoluminescente/tendências , Dosimetria/análise , Dosimetria/classificaçãoRESUMO
This article details the specifications authorised for human use in the clinical practice for the radiopharmaceutical products composed of iobenguane ((123)I) marketed in Spain.
Assuntos
3-Iodobenzilguanidina , Radioisótopos do Iodo , Medicina Nuclear/legislação & jurisprudência , Compostos Radiofarmacêuticos , 3-Iodobenzilguanidina/administração & dosagem , 3-Iodobenzilguanidina/efeitos adversos , 3-Iodobenzilguanidina/farmacocinética , Adolescente , Adulto , Idoso , Animais , Criança , Contraindicações , Cães , Overdose de Drogas , Feminino , Humanos , Lactente , Recém-Nascido , Radioisótopos do Iodo/administração & dosagem , Radioisótopos do Iodo/efeitos adversos , Radioisótopos do Iodo/farmacocinética , Lactação , Legislação de Medicamentos , Masculino , Pessoa de Meia-Idade , Gravidez , Lesões por Radiação/etiologia , Lesões por Radiação/prevenção & controle , Radiometria , Compostos Radiofarmacêuticos/administração & dosagem , Compostos Radiofarmacêuticos/efeitos adversos , Compostos Radiofarmacêuticos/farmacocinética , Ratos , Espanha , Adulto JovemRESUMO
Este artículo detalla las condiciones de usohumano autorizadas en la práctica clínica para los radiofármacos compuestos de iobenguano (123I) legalmente comercializados en España
This article details the specifications authorisedfor human use in the clinical practice for the radiopharmaceutical products composed of iobenguane (123I) marketed in Spain (AU)
Assuntos
Humanos , Animais , Masculino , Feminino , Gravidez , Recém-Nascido , Lactente , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Cães , Ratos , Radioisótopos do Iodo/administração & dosagem , Radioisótopos do Iodo/efeitos adversos , Legislação de Medicamentos , Medicina Nuclear/legislação & jurisprudência , Compostos Radiofarmacêuticos/administração & dosagem , Compostos Radiofarmacêuticos/efeitos adversos , Lactação , Radiometria , EspanhaRESUMO
Avascular osteonecrosis can be associated with septic arthritis and osteomyelitis. Combined labeled leukocyte-marrow imaging scintigraphy has demonstrated excellent accuracy for the detection of infection since both tracers accumulate in the bone marrow and only leukocytes accumulate in infection. We report an unusual total absence of 99mTc HMPAO leukocytes/9mTc-sulfur colloid tracer accumulation, not only in the femoral head but also in the acetabulum and hip in hip osteonecrosis secondary to septic arthritis and osteomyelitis.
Assuntos
Artrite Infecciosa/complicações , Medula Óssea/diagnóstico por imagem , Necrose da Cabeça do Fêmur/diagnóstico por imagem , Leucócitos , Osteomielite/complicações , Medronato de Tecnécio Tc 99m/análogos & derivados , Acetábulo/diagnóstico por imagem , Artrite Infecciosa/diagnóstico por imagem , Quimiotaxia de Leucócito , Feminino , Necrose da Cabeça do Fêmur/etiologia , Radioisótopos de Gálio , Humanos , Pessoa de Meia-Idade , Osteomielite/diagnóstico por imagem , Ossos Pélvicos/diagnóstico por imagem , Cintilografia , Compostos Radiofarmacêuticos , Tecnécio Tc 99m Exametazima , Coloide de Enxofre Marcado com Tecnécio Tc 99mRESUMO
La osteonecrosis avascular puede asociarse con artritis séptica y osteomielitis. La gammagrafía combinada de médula ósea y leucocitos marcados ha demostrado una excelente fiabilidad para la detección de infección, ya que ambos marcadores se acumulan en la médula ósea y únicamente los leucocitos se concentran en los focos infecciosos. Presentamos un caso atípico de ausencia completa de acúmulo de sulfuro coloidal-99mTc y leucocitos-HMPAO-99mTc, no sólo en la cabeza femoral sino también en el acetábulo y pelvis, en osteonecrosis de la cadera secundaria a artritis séptica y osteomielitis (AU)
Assuntos
Pessoa de Meia-Idade , Feminino , Humanos , Leucócitos , Medronato de Tecnécio Tc 99m , Coloide de Enxofre Marcado com Tecnécio Tc 99m , Tecnécio Tc 99m Exametazima , Compostos Radiofarmacêuticos , Ossos Pélvicos , Osteomielite , Artrite Infecciosa , Quimiotaxia de Leucócito , Acetábulo , Radioisótopos de Gálio , Medula Óssea , Necrose da Cabeça do FêmurRESUMO
Anterior temporal lobectomy offers a high chance of seizure-free outcome in patients suffering from drug-refractory complex partial seizure (CPS) originating from the temporal lobe. Other than EEG, several functional and morphologic imaging methods are used to define the spatial seizure origin. The present study was undertaken to compare the merits of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET), magnetic resonance imaging (MRI) and single-voxel proton MR spectroscopy (MRS) for the lateralization of temporal lobe seizure foci. The clinical charts and imaging data of 43 consecutive CPS patients were reviewed. Based on surface EEG, 31 patients were classified with temporal lobe epilepsy (TLE; 25 lateralized, 6 not lateralized) and 12 with non-temporal lobe epilepsy. All were examined by FDG-PET, MRS and MRI within 6 weeks. FDG-PET and MRI were interpreted visually, while the N-acetyl-aspartate to creatine ratio was used for MRS interpretation. One FDG-PET scan was invalid due to seizure activity post injection. The MR spectra could not be evaluated in five cases bilaterally and three cases unilaterally for technical reasons. A total of 15 patients underwent anterior temporal lobectomy. All showed a beneficial postoperative outcome. When the proportions of agreement between FDG-PET (0.77), MRI (0.58) and MRS (0.56) and surface EEG in TLE cases were compared, there were no significant differences (P>0.10). However, FDG-PET showed a significantly higher agreement (0.93) than MRI (0.60; P=0.03) with the side of successful temporal lobectomy. The concordance of MRS with the side of successful temporal lobectomy was intermediate (0.75). When the results of functional and morphologic imaging were combined, no significant differences were found between the rates of agreement of FDG-PET/MRI and MRS/MRI with EEG (0.80 vs 0.68; P=0.50) and with the side of successful temporal lobectomy (0.87 vs 0.92; P=0.50) in TLE cases. However, MRS/MRI showed significantly more lateralized temporal lobe abnormalities in non-temporal lobe epilepsy cases than FDG-PET/MRI (0.90 vs. 0.17; P<0.01). Although FDG-PET seems to be the most reliable and stable method for this purpose, we conclude that in TLE cases it may be justified to perform MRS, which is less expensive, faster and has no radiation exposure, in combination with MRI before FDG-PET, since FDG-PET offers little additional diagnostic information if MRS and MRI indicate the same seizure focus lateralization.
Assuntos
Epilepsia Parcial Complexa/diagnóstico , Epilepsia Parcial Complexa/fisiopatologia , Fluordesoxiglucose F18 , Imageamento por Ressonância Magnética , Espectroscopia de Ressonância Magnética , Compostos Radiofarmacêuticos , Tomografia Computadorizada de Emissão , Adolescente , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos RetrospectivosRESUMO
BACKGROUND: The association of hyperglycaemia with reduced fluorodeoxyglucose (FDG) uptake by tumour cells is well established. Therefore, it is standard practice that all patients must fast for at least several hours prior to FDG positron emission tomography (PET) imaging. However, the effect of hyperglycaemia on FDG uptake by inflammatory and infectious lesions is unknown. The aim of this study was to investigate this important issue. METHODS: For in vitro studies human mononuclear cells were isolated from 12 normal volunteers and FDG uptake was determined in medium containing differing concentrations of glucose. FDG uptake by human mesothelioma cells was also measured for comparison. For studies involving patients, 416 FDG PET scans of patients with confirmed malignancy (n=321) or benign lesions (n=95) were reviewed retrospectively. The relationship between serum glucose level and FDG uptake by the lesions was assessed utilizing the standardized uptake value (SUV) technique. RESULTS: In the in vitro studies, while FDG uptake by mesothelioma cells decreased as glucose concentration increased, there was no differential uptake of FDG uptake by mononuclear cells at glucose concentrations less than 250 mg x dl(-1). In clinical patients, FDG uptake by malignant lesions was slightly, but negatively affected by serum glucose level (r= -0.21, P<0.01) (glucose range 49-187 mg x dl(-1)). In contrast, FDG uptake by inflammatory lesions was positively associated with serum glucose level (r=0.43, P<0.01) (glucose range 54-215 mg x dl(-1)). DISCUSSION AND CONCLUSION: While the degree of FDG uptake is primarily influenced by the nature of the underlying lesion, serum glucose concentration appears to have a small effect on FDG uptake, which differs between malignant disorders and inflammatory processes. Our data suggest that below a certain level, elevated glucose concentration might not have a negative effect on FDG uptake in inflammatory cells, contrary to that observed in malignant disorders.
Assuntos
Glicemia/metabolismo , Fluordesoxiglucose F18/farmacocinética , Inflamação/diagnóstico por imagem , Inflamação/metabolismo , Neoplasias/diagnóstico por imagem , Neoplasias/metabolismo , Compostos Radiofarmacêuticos/farmacocinética , Humanos , Mesotelioma/metabolismo , Monócitos/diagnóstico por imagem , Monócitos/metabolismo , Estudos Retrospectivos , Tomografia Computadorizada de Emissão , Células Tumorais CultivadasRESUMO
No disponible
Assuntos
Pessoa de Meia-Idade , Masculino , Humanos , Eritrócitos , Tecnécio , Neoplasias da Vesícula BiliarAssuntos
Glândulas Salivares/diagnóstico por imagem , Salivação/fisiologia , Síndrome de Sjogren/diagnóstico por imagem , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Valor Preditivo dos Testes , Cintilografia , Glândulas Salivares/fisiopatologia , Síndrome de Sjogren/fisiopatologiaAssuntos
Transplante de Rim/fisiologia , Rim/diagnóstico por imagem , Complicações Pós-Operatórias/diagnóstico , Ureter/diagnóstico por imagem , Adulto , Drenagem , Feminino , Humanos , Complicações Pós-Operatórias/diagnóstico por imagem , Cintilografia , Compostos Radiofarmacêuticos , Tecnécio Tc 99m MertiatidaAssuntos
Rim/anormalidades , Rim/diagnóstico por imagem , Compostos Radiofarmacêuticos , Tecnécio Tc 99m Mertiatida , Ureter/anormalidades , Adulto , Humanos , Rim/patologia , Imageamento por Ressonância Magnética , Masculino , Pelve/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Obstrução Ureteral/etiologia , Obstrução Ureteral/cirurgia , UrografiaRESUMO
OBJECTIVE: Estimation of reference values for basal serum concentrations of adrenocorticotropic hormone (ACTH), cortisol, 11-deoxycortisol, 17-OH-progesterone (17-OHP), plasma renin activity (PRA), aldosterone, -4-androstendione ( 4A) and dehydroepiandrosterone sulphate (DHA-S) in healthy children from Zaragoza. METHODS: Reference population were healthy children aged 0 to 14, with normal weight and height, living in the metropolitan area of Zaragoza (Spain). It is a transversal study. Reference values and ranges for ACTH, cortisol, 11-deoxycortisol, 17-OHP, PRA, aldosterone, 4A and DHA-S were estimated, and changes in concentrations were analyzed in relation to age, sex and puberal stage. RESULTS: Reference values have been classified by puberal stage and age in eleven groups for every sex: Tanner I (umbilical cordon, 3 days, 4-30 days, 1-6 months, 6 months-4 years, 4-7 years, 7-10 years, 10-14 years), Tanner II, Tanner III and Tanner IV-V. Sex did not influence ACTH, cortisol, 17-OHP and PRA concentrations, and there are punctual differences in 11-deoxycortisol, aldosterone, 4A and DHA-S levels. 17-OHP, 11-deoxycortisol and aldosterone concentrations significantly decreased from birth to 6 months-4 years and subsequently kept steady. The maximal concentration of ACTH, and ARP in blood cord significantly decreased until the period 6 months-4 years, and subsequent differences among different age groups, and between prepuberal and puberal groups are scarce. The highest concentration of 4A and DHA-S were observed in blood cord and third day of life, decreased until the lowest level in 6 months-4 years and progressively increased with age in prepuberty, and between prepuberty and puberty. The lowest concentration of cortisol was detected in 4-30 days, increased until 6 months-4 years and kept steady along the prepuberty and puberty. CONCLUSION: It is necessary that every population establish own reference values for ACTH, cortisol, 11-deoxycortisol, 17-OHP, PRA, aldosterone, 4A and DHA-S during infancy, childhood and adolescence, according to age, sex and puberal stage.
Assuntos
Corticosteroides/sangue , Adolescente , Criança , Pré-Escolar , Estudos Transversais , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Valores de Referência , Espanha , População UrbanaRESUMO
OBJECTIVE: To evaluate intraobserver and interobserver agreement in the qualitative interpretation of dynamic salivary radionuclide scans to detect salivary disease, and the agreement between interpretation of dynamic and static image compositions. MATERIAL AND METHODS: Two observers (A, B) interpreted 110 dynamic salivary radionuclide scans with excretory stimulation based on dynamic image composition. Both again interpreted every studies: A based on dynamic image composition and B on static image composition. Kappa statistics were used to determine the degree of intraobserver and interobserver agreement. RESULTS: Considering all the studies, the dynamic composition showed an intraobserver agreement of 0.76 and interobserver agreements of 0.58 and 0.61. In patients with clinical sicca syndrome, agreements were 0.60, 0.52 and 0.62, respectively. For all the cases, the agreements between dynamic and static composition was 0.62 (intraobserver), and 0.42 and 0.43 (interobserver). For patients with clinical sicca syndrome these agreements were 0.63 (intraobserver), and 0.36 and 0.51 (interobserver). CONCLUSION: Intraobserver and interobserver agreement in the qualitative interpretation of dynamic salivary radionuclide scan with excretory stimulation are moderate and notable-moderate overall and in patients with clinical sicca syndrome. These agreements are greater than between dynamic and static image composition.